Northwestern Mutual Wealth Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
EC
SB
RI
RG
GPP
APM
CC
Northwestern Mutual Wealth Management's NGNE Position: Q2 2024 in Review
Northwestern Mutual Wealth Management sold out of Neurogene (NGNE) in Q2 2024, closing a stake of 5 shares — an estimated $255 sold.
Northwestern Mutual Wealth Management first reported a position in NGNE in Q1 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 66 funds tracked by Wall St. Rank hold NGNE as of Q2 2024.
- Northwestern Mutual Wealth Management reported no remaining Neurogene position as of Q2 2024 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 5 Neurogene shares in Q2 2024, an estimated $255.
- Northwestern Mutual Wealth Management first reported a position in Neurogene in Q1 2020 and held it in 2 quarters.
- Northwestern Mutual Wealth Management's Neurogene position peaked at $1K in Q1 2020.
- 66 funds tracked by Wall St. Rank held Neurogene as of Q2 2024.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.